阿糖胞苷代谢酶与急性髓系白血病患者临床耐药关系的研究
被引量:3
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2005年第12期748-750,共3页
Chinese Journal of Hematology
基金
上海市卫生局科研基金资助项目(034080)
参考文献7
-
1Schroder K, Kirch C, Flasshove M, et al. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro. Leukemia, 1996,10:1919-1924.
-
2Mansson E, Liliemark E, Soderhall S, et al. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia. Leukemia, 2002,16: 386-392.
-
3Flasshove M, Strumberg D, Ayscute E, et al. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia, 1994,8:780-785.
-
4Colly LP, Peters WG, Richel D, et al. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia. Semin Oncol, 1987,14: 257-261.
-
5Jahns-Streubel G, Reuter C, Auf der Landwehr U, et al. Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemia. Blood, 1997, 90: 1968-1976.
-
6Heuvel-Eibrink MM, Wiemer EA, Ewijpers M, et al. Absence of mutations in the deoxycytidine kinase ( DCK ) gene in patients with relapsed and/or refractory acute myeloid leukemia(AML). Leukemia,2001,15: 855-856.
-
7Stegmann APA, Honders MW, Willemze R, et al. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine(Ara-C) and 5-aza-2'-deoxycytidine(DAC). Leukemia, 1995,9: 1032-1038.
同被引文献34
-
1唐跃年,张菀陵.阿糖胞苷及其代谢物在血液中的HPLC测定方法[J].中国药学杂志,1994,29(6):352-354. 被引量:4
-
2彭娟红,胡建达.胞苷脱氨酶与阿糖胞苷耐药[J].国际输血及血液学杂志,2006,29(3):257-259. 被引量:1
-
3Rowe JM.What is the best induction regimen for acute myelogenous leukemia[J] ? Leukemia,1998,12(Suppl 1):S16-S19.
-
4Willemze R,Suciu S,Archimbaud E,et al.A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia:an EORTC Leukemia Cooperative Group phase II study (06893)[J].Leukemia 1997,11(Suppl 1):S24-S27.
-
5Hu XF,Slater A,Kantharidis P,et al.Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia[J].Blood,1999,93(12):4086-4095.
-
6Flasshove M,Strumberg D,Ayscute L,et al.Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside[J].Leukemia,1994,8(5):780-785.
-
7Gandhi V,Huang P,Chapman AJ,et al.Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha:affinity,interaction,and consequences[J].Clin Cancer Res,1997,3(8):1347-1355.
-
8Johansson M,Norda A,Karlsson A.Conserved gene structure and transcription factor sites in the human and mouse deoxycytidine kinase genes[J].FEBS Lett,2000,487(2):209-212.
-
9Hatzis P,Al-Madhoon AS,Jüllig M,et al.The intracellular localization of deoxycytidine kinase.[J].J Biol Chem,1998,273(46):30239-30243.
-
10Shi JY,Shi ZZ,Zhang SJ,et al.Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients[J].Pharmacogenetics,2004,14(11):759-768.
引证文献3
-
1杨冠群,陈芳源.阿糖胞苷代谢酶的单核苷酸多态性与其临床疗效的关系[J].内科理论与实践,2010,5(1):96-98. 被引量:1
-
2杨冠群,陈芳源,万海霞,钟华,王海嵘,钟济华,蔡佳翌,欧阳仁荣.DCK基因多态性与阿糖胞苷治疗急性髓系白血病疗效的关系[J].上海交通大学学报(医学版),2010,30(6):717-721.
-
3孟冬梅,肖翔林,陈福雄,卫凤桂.儿童急性白血病不同阿糖胞苷化疗方案的药物动力学研究[J].中国药师,2010,13(9):1233-1235.
-
1刘西平.肿瘤细胞对阿糖胞苷耐药性与脱氧胞苷激酶[J].中华血液学杂志,1996,17(7):385-387.
-
2李威,谢晓恬,蒋莎义,张虹,李福兴,周妮娜,曹萍.阿糖胞苷代谢关键酶基因在儿童恶性血液肿瘤中的表达[J].中国小儿血液与肿瘤杂志,2010,15(5):208-211. 被引量:5
-
3万海霞,陈芳源,赵劲秋,欧阳仁荣.脱氧胞苷激酶与白血病耐药的关系[J].上海第二医科大学学报,2005,25(2):185-187. 被引量:2
-
4何祥梁,郭先健.胞苷脱氨酶基因治疗肿瘤研究进展[J].河南肿瘤学杂志,2000,13(1):76-77.
-
5陈芳源,陆虹旻,宣正华,韩洁英,滕晔,欧阳仁荣.急性白血病细胞内dCK和CDA含量与临床疗效的关系[J].上海医学,2001,24(5):266-269. 被引量:5
-
6谢晓恬,蒋莎义,李本尚,杨莉莉.急性白血病、恶性淋巴瘤患儿大剂量阿糖胞苷治疗的药代动力学及代谢关键酶基因表达研究[J].中华儿科杂志,2008,46(4):276-280. 被引量:12
-
7杨冠群,陈芳源.阿糖胞苷代谢酶的单核苷酸多态性与其临床疗效的关系[J].内科理论与实践,2010,5(1):96-98. 被引量:1
-
8彭娟红,胡建达.胞苷脱氨酶与阿糖胞苷耐药[J].国际输血及血液学杂志,2006,29(3):257-259. 被引量:1
-
9赵晓甦,孙志强,江滨,王德炳.急性白血病患者胞苷脱氨酶活性改变的临床意义[J].北京大学学报(医学版),2008,40(2):181-184. 被引量:1
-
10马经野,罗先红,方海琳.急性白血病病人胞苷脱氨酶基因多态性对阿糖胞苷疗效的影响[J].中国现代医学杂志,2005,15(14):2150-2152. 被引量:2